Today: July 8, 2015, 6:45 am
GE Healthcare Announces European Union Approval of VIZAMYL™ (Flutemetamol (18F) Solution for Injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer’s Disease 2014-09-01 09:03:01

GE Healthcare
Scott Lerman
+1 609 514 6346 (office)
+1 609 937 9253 (mobile)

Press Information

Published by
Hossam Abdel-Kader
+43 1 9582319
Related Articles

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.